Blood Lipid-Lowering Protein FGF21 (IMAGE)

Umea University

Blood Lipid-Lowering Protein FGF21

Caption

The protein FGF21 is an exciting potential therapeutic agent for the treatment of cardiovascular diseases and type 2 diabetes. Researchers in this study have investigated what mechanisms are responsible for the protein's reducing of blood lipid levels. The results show that FGF21 lowers the release of free fatty acids from the white adipose tissue, which decreases the release of liver produced blood lipids.

Credit

Stefan K Nilsson

Usage Restrictions

This graphical abstract may only be used in contexts relating to this news release.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.